


Turning NHS EPD Data into Actionable Insight
Merlinn, offers the clearest public signal of true prescribing behaviour in England. By embedding NHS England Prescription Data (EPD) into Merlinn, this public dataset is transformed into a strategic advantage for pharmaceutical manufacturing and distribution efficiency.
Trial Subscription
FREE
For Companies that want to try it for a limited time
-
Data Available at Chemical Level
-
Min 5 Chemicals
-
Customers may Purchase additional bundles of 5 Chemicals

Green Subscription
ASK FOR PRICE
For Companies with Broader Portfolios
-
Data Available at Chapter level (data of 1 Chapter include arround 60 -120 chemicals)
-
Min 1 Chapter
-
Includes Region, ICB, PCO, City and Surgery-level insights.
-
2 Users Included
-
BD Module is not included

Yellow Subscription
£ 1.250/Month
For Companies with Smaller Portfolios
-
Data Available at Chemical Level
-
Min 5 Chemicals
-
Includes Region, ICB, PCO, City and Surgery-level insights.
-
Customers may Purchase additional bundles of Chemicals
-
1 User Included, additional users £350 per month.
-
BD Module is not included
-
VAT is not Included

Blue Subscription
ASK FOR PRICE
For Full Market Analysis
-
Full market access across all Chapters. (21 Chapter, 1.650 Chemical )
-
Includes Region, ICB, PCO, City and Surgery-level insights.
-
2 Users Included
-
BD Module is not included


Merlinn Business Development (BD) Module
The Merlinn Business Development Module is designed to help pharmaceutical companies move beyond traditional reporting and into strategic decision-making. It is powered by proprietary Pricing Data developed by Triton BIT, which has been processed and segmented to identify:
-
Profitable chemicals to operate in.
-
Opportunities where manufacturing adjustments can deliver additional benefits.
-
Areas where focused strategy can generate the highest return on investment.
By combining NHS prescription data with Triton BIT’s Pricing Data and AI-driven simulations, the BD Module enables companies to explore future scenarios, risks, and opportunities in a structured, evidence-based way.
Merlinn Business Development (BD) Module – Premium Add-On
The Merlinn Business Development Module is a premium extension designed for companies that want to move beyond reporting and into strategic scenario planning. Powered by Triton BIT’s proprietary Pricing Data, the module provides segmentation by chemical, identifies profitable opportunities, and enables advanced simulations across manufacturing, sales & distribution, and international expansion.
Because of its strategic value and unique data foundation, the BD Module is offered as a premium add-on to Merlinn’s subscription tiers or as a standalone suite:
Pricing Options
Blue Subscription + BD Module
-
Full market access across all Chapters. (21 Chapter, 1.650 Chemical )
-
Includes Region and City-level insights.
-
+ BD Modules
-
2 users included
Standalone BD Suite
-
Available as a standalone product or as an add-on to any panel.
-
Specially Developed Molecule Segmentation.
-
Pricing and revenue impact scenarios.
-
Manufacturing optimization and supply chain risk simulations.
-
1 user included
Green Subscription + BD Module
-
Access at Chapter level (includes data of 1 Chapter).
-
Includes Region and City-level insights.
-
Specially Developed Molecule Segmentation.
-
+BD Module (Chapter molecules)
-
2 users included
Amber Panel
-
Everything to decide to come to the UK
-
Molecule Segmentation
-
Grow your business scenario
-
Molecule Sales Report by Geo
-
Reach to Consultancy Supplier for Regulations, Legal and Business
Value Proposition
With the BD Module, Merlinn evolves from an analytics platform into a strategic companion — helping leadership teams:
-
Identify the most profitable chemicals to invest in.
-
Optimise manufacturing and supply chain decisions using AI-powered analysis.
-
Model the impact of pricing and market share changes on revenue.
-
Explore international markets with the strongest growth potential.
This ensures strategic decisions are grounded in data-driven evidence, not assumptions — giving companies a measurable advantage in today’s competitive market.
